tiprankstipranks
Trending News
More News >
OncoZenge AB (DE:8LY)
FRANKFURT:8LY

Compare OncoZenge AB (8LY) vs. Competitors

Compare
0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
OncoZenge AB
€0.59
€6.21M
-8.78
-0.40%
LIDDS AB
kr0.04
kr2.43M
-0.51
-86.00%
Lipigon Pharmaceuticals AB
kr0.01
kr7.27M
-0.08
-91.54%
Modus Therapeutics Holding AB
kr0.30
kr37.70M
-1.37
-42.38%
ExpreS2ion Biotech Holding AB
kr17.10
kr51.97M
-0.79
-52.81%
Sprint Bioscience AB
kr1.48
kr171.46M
-5.39
5.66%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:8LY
OncoZenge AB
0.50
0.04
9.21%
SE:LIDDS
LIDDS AB
0.02
-0.13
-86.00%
SE:LPGO
Lipigon Pharmaceuticals AB
0.01
-0.12
-91.67%
SE:MODTX
Modus Therapeutics Holding AB
0.31
-0.23
-42.38%
SE:EXPRS2
ExpreS2ion Biotech Holding AB
14.44
-14.96
-50.88%
SE:SPRINT
Sprint Bioscience AB
1.63
0.05
2.91%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts